🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 657.76 -0.6% NASDAQ 100: 590.38 -0.8% Dow Jones: 459.51 -0.8%

Cliff Asness’s PRCT Holdings & Trades

First Buy
Q2 2024
Duration Held
7 Quarters
Largest Add
Q2 2025
+34,562 Shares
Current Position
43,058 Shares
$1.35 M Value

Cliff Asness's PRCT Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 43,058 shares of PROCEPT BioRobotics Corporation (PRCT) worth $1.35 M, representing 0.00% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 7 quarters.

Based on 13F filings, Cliff Asness has maintained this position in PRCT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 34,562 shares. Largest reduction occurred in Q4 2025, reducing 23,283 shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's PROCEPT BioRobotics Corporation (PRCT) Holding Value Over Time

Track share changes against reported price movement

Quarterly PROCEPT BioRobotics Corporation (PRCT) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 -23,283 Reduce 35.10% 43,058 $31.46
Q3 2025 +12,887 Add 24.11% 66,341 $35.69
Q2 2025 +34,562 Add 182.95% 53,454 $57.60
Q1 2025 +1,286 Add 7.30% 18,892 $58.26
Q4 2024 +8,590 Add 95.28% 17,606 $80.52
Q3 2024 +3,877 Add 75.44% 9,016 $80.12
Q2 2024 +5,139 New Buy 5,139 $61.09

Cliff Asness's PROCEPT BioRobotics Corporation Investment FAQs

Cliff Asness first purchased PROCEPT BioRobotics Corporation (PRCT) in Q2 2024, acquiring 5,139 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held PROCEPT BioRobotics Corporation (PRCT) for 7 quarters since Q2 2024.

Cliff Asness's largest addition to PROCEPT BioRobotics Corporation (PRCT) was in Q2 2025, adding 53,454 shares worth $3.08 M.

According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 43,058 shares of PROCEPT BioRobotics Corporation (PRCT), valued at approximately $1.35 M.

As of the Q4 2025 filing, PROCEPT BioRobotics Corporation (PRCT) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in PROCEPT BioRobotics Corporation (PRCT) was 66,341 shares, as reported at the end of Q3 2025.